There is a newer version of the record available.

Published November 13, 2025 | Version 1.2

Predictive Bioharmonics: Mathematical Validation of the Pre-Diagnostic Phase Identified in the PanSeer Study

  • 1. Creator of Predictive Bioharmonics and Inventor and Founder of Elixira

Description

Predictive Bioharmonics introduces the first mathematical model capable of predicting when biological harmony transitions into measurable disorder — before disease becomes clinically detectable. The model complements and mathematically explains the early biological drift detected by PanSeer. By deriving a universal harmonic–dissonant drift sequence based on the Golden Ratio (φ = 1.618), the Predictive Bioharmonic Threshold (√φ ≈ 1.272), and the inverted Fibonacci onset of measurable disease (ΔΦ ≈ 1.701), this framework quantifies early biological drift.

The PanSeer study (Nature Communications, 2020) showed that cancer-associated methylation signals appear up to four years before diagnosis. The mathematical progression presented here aligns with this timing, revealing the same point where harmony breaks enough to be detected.

This paper outlines the full theoretical model, core equations, validation algorithms, and analysis pipeline, and identifies the moment when biological self-correction fails. Together, these findings support a shift from reactive medicine to pre-care — where disharmony may be identified and corrected long before symptoms arise.

Files

Predictive_Bioharmonics_Mathematical_Validation_of_the_Pre-Diagnostic_Phase_Identified_in_the_PanSeer_Study.pdf

Additional details

Dates

Updated
2025-11-13
Clarified wording to distinguish early mathematical dissonance (≈1.1–1.2) from the first detectable point of disease at ΔΦ ≈ 1.701.